Raymond James Trust N.A. Reduces Stake in HCA Healthcare, Inc. (NYSE:HCA)

Raymond James Trust N.A. decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.6% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 14,918 shares of the company’s stock after selling 90 shares during the period. Raymond James Trust N.A.’s holdings in HCA Healthcare were worth $6,063,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCA. Bangor Savings Bank increased its position in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $28,000. GPS Wealth Strategies Group LLC increased its position in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare in the second quarter valued at approximately $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on HCA shares. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. KeyCorp dropped their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Six analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.00.

HCA Healthcare Price Performance

HCA stock opened at $324.92 on Friday. The company has a market cap of $82.30 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 1.28 and a beta of 1.68. HCA Healthcare, Inc. has a 12-month low of $245.84 and a 12-month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a 50-day moving average price of $379.40 and a two-hundred day moving average price of $358.05.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 over the last three months. 1.60% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.